Ann: March 2025 Quarterly Activities Report & Appendix 4C, page-14

PR may eventually be regaled at dinner parties for his advancements in the field of knee osteoarthritis. A few unfortunate PAR shareholders may be quick to point out his detrimental tardiness effects to the field of their coronary health. Clearly the immediate cash requirements pushed out vs expectations/guidance:



But the expenses and need for capital only pushed out a couple of months at best:


He literally has 3 months to get a partnership deal announced - stating the obvious, but getting any necessary bridging finance a breeze whilst cash movements formalised thereafter - or the market/investors will get very jittery again (if they were not already).

He really does take the p*ss with investors patience. The guidance on the glaring elephant in the room (or rather large space where we expect/hope an elephant) really, as ever, requires yet another small leap of faith/trust and we will be no doubt taken, right down to the deadline:



They'd best be "advanced" and near completion.

Good luck PAR holders. I think he will get the company and remaining shareholders over the line, but many have fallen in the promised 10km run, he turned into marathon already, and those left will be exhausted.